The University of Southampton
University of Southampton Institutional Repository

A call to action: a consensus statement on knowledge gaps and research priorities on the management of women with early onset type 2 diabetes in the preconception, pregnancy and postnatal periods: A report from the Diabetic Medicine Symposium at the Diabetes UK Annual Professional Conference, 2025

A call to action: a consensus statement on knowledge gaps and research priorities on the management of women with early onset type 2 diabetes in the preconception, pregnancy and postnatal periods: A report from the Diabetic Medicine Symposium at the Diabetes UK Annual Professional Conference, 2025
A call to action: a consensus statement on knowledge gaps and research priorities on the management of women with early onset type 2 diabetes in the preconception, pregnancy and postnatal periods: A report from the Diabetic Medicine Symposium at the Diabetes UK Annual Professional Conference, 2025

AIMS: Research to inform, co-develop and evaluate optimal care for women with early-onset type 2 diabetes (EOT2D) before, during and after pregnancy is lacking. Informed by patient perspectives and the results of the James Lind Alliance priority-setting partnership in diabetes in pregnancy, we aimed to develop a consensus statement to guide future research efforts to meet the needs of women with EOT2D in the preconception, pregnancy and postnatal periods.

METHODS: Results from three systematic reviews covering interventional, observational and qualitative studies were presented at the Diabetes UK annual professional conference in Glasgow in February 2025. The results were discussed by an expert panel with audience participation.

RESULTS: There is very limited research to guide care for women with EOT2D, especially in the preconception and postnatal periods. In pregnancy, there have been limited studies assessing interventions, mainly encompassing medication and glucose sensor use, but most are small and have limited generalisability. Observational data suggests that managing glycaemia, addressing maternal BMI and preventing excessive gestational weight gain improve outcomes for women with EOT2D in pregnancy. Qualitative data highlight the negative impact of EOT2D on pregnancy and the need for optimised support. Targeted, innovative and cross-cultural studies across the reproductive life course are urgently needed to address the short and longer-term maternal and offspring risks for individuals with EOT2D.

CONCLUSIONS: Given the rising prevalence of EOT2D and the risk of adverse pregnancy outcomes for women with EOT2D and their children, prioritising research in the preconception, pregnancy and postnatal periods is vital to ensure that care needs are met to improve health outcomes for women and their children.

early-onset type 2 diabetes, neonatal, outcomes, postnatal, preconception, pregnancy
1464-5491
e70252
White, Sara L
7c2d382b-89ff-4535-9f86-b542f0e7d20e
Schoenaker, Danielle
84b96b87-4070-45a5-9777-5a1e4e45e818
Mackin, Sharon
6846cf26-6d01-46df-93d6-e23dd54d9aac
Forde, Rita
2694acef-6e54-4e63-8fc7-d70336b7f6e6
Flynn, Angela C
831cdbee-7c6f-4cce-859c-4365457d1bb9
Dyer, Eleanor
ebfa2191-3f62-4baf-8915-8b9df771475a
Heslehurst, Nicola
c6742f44-d9ad-42af-b3d8-87311baa54b4
Lindsay, Robert
9508787f-a0b6-4155-95f7-33c57e4f56a0
Meek, Claire L
5fee5eba-aa22-4446-bffd-d3622c7b425d
White, Sara L
7c2d382b-89ff-4535-9f86-b542f0e7d20e
Schoenaker, Danielle
84b96b87-4070-45a5-9777-5a1e4e45e818
Mackin, Sharon
6846cf26-6d01-46df-93d6-e23dd54d9aac
Forde, Rita
2694acef-6e54-4e63-8fc7-d70336b7f6e6
Flynn, Angela C
831cdbee-7c6f-4cce-859c-4365457d1bb9
Dyer, Eleanor
ebfa2191-3f62-4baf-8915-8b9df771475a
Heslehurst, Nicola
c6742f44-d9ad-42af-b3d8-87311baa54b4
Lindsay, Robert
9508787f-a0b6-4155-95f7-33c57e4f56a0
Meek, Claire L
5fee5eba-aa22-4446-bffd-d3622c7b425d

White, Sara L, Schoenaker, Danielle, Mackin, Sharon, Forde, Rita, Flynn, Angela C, Dyer, Eleanor, Heslehurst, Nicola, Lindsay, Robert and Meek, Claire L (2026) A call to action: a consensus statement on knowledge gaps and research priorities on the management of women with early onset type 2 diabetes in the preconception, pregnancy and postnatal periods: A report from the Diabetic Medicine Symposium at the Diabetes UK Annual Professional Conference, 2025. Diabetic medicine : a journal of the British Diabetic Association, 43 (5), e70252. (doi:10.1111/dme.70252).

Record type: Article

Abstract

AIMS: Research to inform, co-develop and evaluate optimal care for women with early-onset type 2 diabetes (EOT2D) before, during and after pregnancy is lacking. Informed by patient perspectives and the results of the James Lind Alliance priority-setting partnership in diabetes in pregnancy, we aimed to develop a consensus statement to guide future research efforts to meet the needs of women with EOT2D in the preconception, pregnancy and postnatal periods.

METHODS: Results from three systematic reviews covering interventional, observational and qualitative studies were presented at the Diabetes UK annual professional conference in Glasgow in February 2025. The results were discussed by an expert panel with audience participation.

RESULTS: There is very limited research to guide care for women with EOT2D, especially in the preconception and postnatal periods. In pregnancy, there have been limited studies assessing interventions, mainly encompassing medication and glucose sensor use, but most are small and have limited generalisability. Observational data suggests that managing glycaemia, addressing maternal BMI and preventing excessive gestational weight gain improve outcomes for women with EOT2D in pregnancy. Qualitative data highlight the negative impact of EOT2D on pregnancy and the need for optimised support. Targeted, innovative and cross-cultural studies across the reproductive life course are urgently needed to address the short and longer-term maternal and offspring risks for individuals with EOT2D.

CONCLUSIONS: Given the rising prevalence of EOT2D and the risk of adverse pregnancy outcomes for women with EOT2D and their children, prioritising research in the preconception, pregnancy and postnatal periods is vital to ensure that care needs are met to improve health outcomes for women and their children.

This record has no associated files available for download.

More information

Accepted/In Press date: 28 January 2026
e-pub ahead of print date: 13 March 2026
Additional Information: © 2026 The Author(s). Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK.
Keywords: early-onset type 2 diabetes, neonatal, outcomes, postnatal, preconception, pregnancy

Identifiers

Local EPrints ID: 510641
URI: http://eprints.soton.ac.uk/id/eprint/510641
ISSN: 1464-5491
PURE UUID: c2b92bea-e170-4302-acee-5caf9f2a71fa
ORCID for Danielle Schoenaker: ORCID iD orcid.org/0000-0002-7652-990X

Catalogue record

Date deposited: 14 Apr 2026 16:57
Last modified: 15 Apr 2026 02:01

Export record

Altmetrics

Contributors

Author: Sara L White
Author: Sharon Mackin
Author: Rita Forde
Author: Angela C Flynn
Author: Eleanor Dyer
Author: Nicola Heslehurst
Author: Robert Lindsay
Author: Claire L Meek

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×